Q3 results confirms that the U.S. vaccine market for respiratory syncytial virus (RSV), led by Pfizer (PFE) and GSK (GSK), is ...

After the US elections results, CEO of the major vaccine maker GSK Emma Walmsley said the sector was adopting ... He went on ...

the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced it is pledging $7.8million to the ‘Fund our Futures’ campaign led by the Global ...

GSK is investing up to $800 million to double ... Through the addition of two new facilities, the project is set to bring on drug substance manufacturing and bolster the company's existing drug ...

GSK plans to invest $800 million in its East Donegal Township vaccine packaging facility over the next four years in an expansion project that would add research and manufacturing capabilities ...

Quarterly sales of GSK's RSV vaccine dropped more than 70%, following narrower recommendations for who should get the shot.

A family-friendly concept is highlighted at the China International Import Expo, ranging from disease care, driving safety ...

Lancaster County projects – 16 of them – were awarded a total of $35.617 million in the most recent round of grants announced ...

GlaxoSmithKline, the London-based pharmaceutical giant with a substantial presence in Montgomery County and Philadelphia, announced a landmark investment ...

Ewing Sarcoma is a Highly Metastatic Form of Sarcoma and the Second Most Prevalent Primary Malignant Tumor in Children and Adolescents Ongoing Enrollment in Phase 1/2 Trial of Elraglusib in ...